Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized prospective phase 2 study of dutasteride to reduce recurrence of non-muscle-invasive bladder cancer
MOH_2018-03-18_002262Phase 2Recruiting
- Sponsor
- ד"ר גל רינות מזרחי
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dutasteride in bladder cancer (2 arms), sponsored by ד"ר גל רינות מזרחי. Started Nov 2017; status: recruiting.
02
Drugs
dutasteride
03
Conditions
bladder cancer
Beyond the preview
Go deeper on MOH_2018-03-18_002262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2018-03-18_002262.